Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin’s lymphoma
Nuklearmedizin - NuclearMedicine · 01.02.2023 · 62 (01) · 20-26
DOI: 10.1055/a-1972-9292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.02.2023. Verfasst von Esra Arslantaş und 6 weiteren Autor:innen. Beteiligte Einrichtung: pediatric hematology oncology, Başakşehir Çam ve Sakura Şehir Hastanesi, Istanbul, Turkey. Hauptthemen laut MEDLINE: Bone Marrow, Hodgkin Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
To compare bone marrow biopsy (BMB) with [18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (PET/CT) imaging in the demonstration of bone marrow involvement in children with Hodgkin’s Lymphoma (HL) and to investigate the effectiveness of PET/CT imaging and thus the necessity for BMB at staging.
Methods
Pediatric patients with HL, who underwent both bilateral iliac BMB and PET/CT imaging at disease staging were retrospectively analyzed. In determining bone marrow involvement (BMinv), BMB and/or first/follow-up PET/CT imaging were eligible for review.
Results
Fifty-six patients were included. BMinv was detected by PET/CT imaging in 6/56 (10.7%), whereas the proportion was 3/56 (5.3%) in BMB specimens. Bone marrow biopsies and PET/CT images were concordant in 53/56 (94.6%) patients with BMB specimens missing three cases of BMinv detected by PET/CT. When diagnostic accuracy was calculated, sensitivity, specificity, positive predictive value and negative predictive values for PET/CT were 100%, 100%, 100%, 100%, respectively, and the same values for BMB were 50%, 100%, 100%, 94.3%, respectively.
Conclusions
The results of PET/CT and BMB for staging of pediatric HL patients were compatible, and PET/CT imaging was found to provide high diagnostic performance in determining BMinv. In keeping with earlier research, the current study showed that BMB may not be necessary in every patient at staging, and should be reserved for cases where PET/CT is inconclusive.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- pediatric hematology oncology, Başakşehir Çam ve Sakura Şehir Hastanesi, Istanbul, Turkey.
- pediatric hematology oncology, İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi, Istanbul, Turkey.
- Pathology, Başakşehir Çam ve Sakura Şehir Hastanesi, Istanbul, Turkey.
- Nuclear Medicine, Başakşehir Çam ve Sakura Şehir Hastanesi, Istanbul, Turkey.
- pediatric hematology oncology, Istinye Universitesi, Istanbul, Turkey.
Zitieren
APA
Arslantaş, E., Ayçiçek, A., Akıcı, F., Özkara, S., Yılmaz, B., Özdemir, N., & Bayram, C. (2023). Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin’s lymphoma. Nuklearmedizin - NuclearMedicine, 62(01), 20-26. https://doi.org/10.1055/a-1972-9292
Vancouver
Arslantaş E, Ayçiçek A, Akıcı F, Özkara S, Yılmaz B, Özdemir N, et al. Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin’s lymphoma. Nuklearmedizin - NuclearMedicine. 2023;62(01):20-26. doi:10.1055/a-1972-9292
BibTeX
@article{Arslanta2023,
author = {Arslantaş, Esra and Ayçiçek, Ali and Akıcı, Ferhan and Özkara, Selvinaz and Yılmaz, Burçak and Özdemir, Nihal and Bayram, Cengiz},
title = {Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin’s lymphoma},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2023},
volume = {62},
number = {01},
pages = {20--26},
doi = {10.1055/a-1972-9292}
}
EUVIMED